Rogers GL - Search Results

1

Reprogramming human B cells with custom heavy chain antibodies.

Rogers GL, Huang C, Mathur A, Huang X, Chen HY, Stanten K, Morales H, Chang CH, Kezirian EJ, Cannon PM. Rogers GL, et al. Res Sq [Preprint]. 2023 Jul 17:rs.3.rs-3117686. doi: 10.21203/rs.3.rs-3117686/v1. Res Sq. 2023. Update in: Nat Biomed Eng. 2024 Dec;8(12):1700-1714. doi: 10.1038/s41551-024-01240-4 PMID: 37503066 Free PMC article. Updated. Preprint.

2

Gene Therapy Approaches to Human Immunodeficiency Virus and Other Infectious Diseases.

Rogers GL, Cannon PM. Rogers GL, et al. Hematol Oncol Clin North Am. 2017 Oct;31(5):883-895. doi: 10.1016/j.hoc.2017.06.008. Hematol Oncol Clin North Am. 2017. PMID: 28895854 Review.

3

Reprogramming the antigen specificity of B cells using genome-editing technologies.

Voss JE, Gonzalez-Martin A, Andrabi R, Fuller RP, Murrell B, McCoy LE, Porter K, Huang D, Li W, Sok D, Le K, Briney B, Chateau M, Rogers G, Hangartner L, Feeney AJ, Nemazee D, Cannon P, Burton DR. Voss JE, et al. Elife. 2019 Jan 17;8:e42995. doi: 10.7554/eLife.42995. Elife. 2019. PMID: 30648968 Free PMC article.

4

Homologous Recombination-Based Genome Editing by Clade F AAVs Is Inefficient in the Absence of a Targeted DNA Break.

Rogers GL, Chen HY, Morales H, Cannon PM. Rogers GL, et al. Mol Ther. 2019 Oct 2;27(10):1726-1736. doi: 10.1016/j.ymthe.2019.08.019. Epub 2019 Sep 9. Mol Ther. 2019. PMID: 31540849 Free PMC article.

5

Reply to "Efficient Nuclease-free HR by Clade F AAV Requires High MOIs with High Quality Vectors".

Rogers GL, Chen HY, Morales H, Cannon PM. Rogers GL, et al. Mol Ther. 2019 Dec 4;27(12):2061-2062. doi: 10.1016/j.ymthe.2019.11.003. Epub 2019 Nov 11. Mol Ther. 2019. PMID: 31735602 Free PMC article. No abstract available.

6

Cytoplasmic Tail Truncation of SARS-CoV-2 Spike Protein Enhances Titer of Pseudotyped Vectors but Masks the Effect of the D614G Mutation.

Chen HY, Huang C, Tian L, Huang X, Zhang C, Llewellyn GN, Rogers GL, Andresen K, O'Gorman MRG, Chen YW, Cannon PM. Chen HY, et al. Among authors: rogers gl. J Virol. 2021 Oct 27;95(22):e0096621. doi: 10.1128/JVI.00966-21. Epub 2021 Sep 8. J Virol. 2021. PMID: 34495700 Free PMC article.

7

Genome edited B cells: a new frontier in immune cell therapies.

Rogers GL, Cannon PM. Rogers GL, et al. Mol Ther. 2021 Nov 3;29(11):3192-3204. doi: 10.1016/j.ymthe.2021.09.019. Epub 2021 Sep 24. Mol Ther. 2021. PMID: 34563675 Free PMC article. Review.

8

Optimization of AAV6 transduction enhances site-specific genome editing of primary human lymphocytes.

Rogers GL, Huang C, Clark RDE, Seclén E, Chen HY, Cannon PM. Rogers GL, et al. Mol Ther Methods Clin Dev. 2021 Sep 10;23:198-209. doi: 10.1016/j.omtm.2021.09.003. eCollection 2021 Dec 10. Mol Ther Methods Clin Dev. 2021. PMID: 34703842 Free PMC article.

9

Reprogramming human B cells with custom heavy chain antibodies.

Rogers GL, Huang C, Mathur A, Huang X, Chen HY, Stanten K, Morales H, Chang CH, Kezirian EJ, Cannon PM. Rogers GL, et al. bioRxiv [Preprint]. 2023 Jun 30:2023.06.28.546944. doi: 10.1101/2023.06.28.546944. bioRxiv. 2023. Update in: Nat Biomed Eng. 2024 Dec;8(12):1700-1714. doi: 10.1038/s41551-024-01240-4 PMID: 37425794 Free PMC article. Updated. Preprint.

10

Comparison of SARS-CoV-2 entry inhibitors based on ACE2 receptor or engineered Spike-binding peptides.

Llewellyn GN, Chen HY, Rogers GL, Huang X, Sell PJ, Henley JE, Cannon PM. Llewellyn GN, et al. Among authors: rogers gl. J Virol. 2023 Aug 31;97(8):e0068423. doi: 10.1128/jvi.00684-23. Epub 2023 Aug 9. J Virol. 2023. PMID: 37555663 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

135 results

Search Page

Filters